PF-06882961 Tris

CAS No. 2230198-03-3

PF-06882961 Tris( UNII-2HJV78O0SS )

Catalog No. M24014 CAS No. 2230198-03-3

PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 272 In Stock
10MG 408 In Stock
25MG 672 In Stock
50MG 945 In Stock
100MG 1278 In Stock
500MG 2547 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-06882961 Tris
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
  • Description
    PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UNII-2HJV78O0SS
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    GLP-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2230198-03-3
  • Formula Weight
    676.7
  • Molecular Formula
    C35H41FN6O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F.C(C(CO)(CO)N)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Méndez M, Matter H, Defossa E, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2020;63(5):2292-2307. doi:10.1021/acs.jmedchem.9b01071
molnova catalog
related products
  • GLP-1R modulator C16

    GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4.

  • GLP-1R modulator L7-...

    GLP-1R modulator L7-028 is a variant that enhances affinity for GLP-1 and (cAMP) signaling.

  • LGD-6972

    LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist.